Suchergebnisse - "Xu, Binghe"

PubPharm (520)

51

Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution

enthalten in: BMC geriatrics | 2023

von Huang, H. | Tang, Y. | Wu, D. | +11

52

Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution

enthalten in: BMC geriatrics | 2023

von Huang, H. | Tang, Y. | Wu, D. | +11

53

Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer

enthalten in: Signal transduction and targeted therapy | 2023

von Guan, X. | Ma, F. | Li, Q. | +7

54

Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer

enthalten in: Cancer biology & medicine | 2023

von Chen, Y. | Wang, X. | Du, F. | +8

55

Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer

enthalten in: Journal of personalized medicine | 2023

von Han, Y. | Wang, J. | Xu, B.

56

Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer : a pooled analysis of two phase I studies

enthalten in: Biomarker research | 2023

von Guan, X. | Ma, F. | Li, Q. | +9

57

Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studies

enthalten in: Biomarker Research | 2023

von Guan, X. | Ma, F. | Li, Q. | +9

58

The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges

enthalten in: The Lancet regional health. Western Pacific | 2023

von Huang, H. | Tang, Y. | Yu, Y. | +31

59

Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN) : final analysis of a phase III, randomized, double-blind, placebo-controlled study

enthalten in: Breast cancer research and treatment | 2023

von Xu, B. | Li, W. | Zhang, Q. | +11

60

Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations : a phase II study

enthalten in: Breast cancer research and treatment | 2023

von Xu, B. | Sun, T. | Shi, Y. | +22